Table 2.
Neutral GSLs | |
---|---|
Disaccharide-ceramide (Hex-Hex-Cer) | Lac-Cer (Gal β4 Glc β1Cer) Digalactosylceramide (Gal α4 Gal β1Cer) |
Trisaccharide-ceramide (Hex-Hex-Hex-Cer) | iGb3 (Gal α3 Gal β4 Glc Cer) Gb3 (Gal α4 Gal β4 Glc Cer) |
Trisaccharide-ceramide (HexNAc-Hex-Hex-Cer) | Lc3 (GlcNAc β3 Gal β4 Glc Cer) Asialo-GM2 (GalNAc β4 Gal β4 Glc Cer) |
Tetrasaccharide-ceramide (HexNAc-Hex-Hex-Hex-Cer) | iGb4 (GalNAc β3 Gal α3 Gal β4 Glc Cer) Gb4 (GalNAc β3 Gal α4 Gal β4 Glc Cer) |
Tetrasaccharide-ceramide (Hex-HexNAc-Hex-Hex-Cer) | Asialo-GM1 (Gal β3 GalNAc β4 Gal β4 Glc Cer) |
Fossman antigen (HexNAc)3-(Hex)2-Cer | GalNAc α3 GalNAc β3 Gal α4 Gal β4 Glc Cer |
| |
Acidic GSLs | |
Monosialyl-gangliosides | GM1 (Gal β3 GalNAc β4 <NeuAc α3> Gal β4 Glc Cer) GM1b (NeuAc α3 Gal β3 GalNAc β4 Gal β4 Glc Cer) |
Disialyl-gangliosides | GD1a (<NeuAc α3> Gal β3 GalNAc β4 <NeuAc α3> Gal β4 Glc Cer) GD1b (Gal β3 GalNAc β4 (<NeuAc α8 NeuAc α3> Gal β4 Glc Cer) GD3 (NeuAc α8 NeuAc α3 Gal β4 Glc Cer) |
Trisialyl-gangliosides | GT1a (<NeuAc 8 NeuAc α3> Gal β3 GalNAc β4 <NeuAc α3> Gal β4 Glc Cer) GT1b (<NeuAc α3> Gal β3 GalNAc β4 < NeuAc 8 NeuAc α3> Gal β4 Glc Cer) |